Parents and kids disagree on the right age to become financially independent, report finds
Parents and their adult children disagree on when to start paying your own way, according to a new Bankrate report.
This strategy could save thousands off the cost of college: ‘It’s a very smart way to start your higher education,’ says expert
In some cases, students can complete an associate degree by the time they finish high school and then transfer to a four-year college as a junior.
EPA reportedly planning to announce significant limits on tailpipe emissions to boost electric vehicle adoption
EPA reportedly planning to announce significant limits on tailpipe emissions to boost electric vehicle adoption.
Microsoft’s $13 billion bet on OpenAI carries huge potential along with plenty of uncertainty
Microsoft’s partnership with OpenAI could mean billions of dollars a year in new revenue, but the investment structure is complicated.
Federal judge suspends FDA abortion pill approval, gives Biden administration time to appeal
A federal judge in Texas on Friday stayed the FDA’s appwroval of the abortion pill mifepristone, but delayed the ruling taking effect for a week, giving time to appeal.
Lawmakers meet with Apple, Disney CEOs as part of talks on competition with China
The trip highlights the key role tech and media industries play in the U.S.’s increasingly complex relationship with China.
Job growth totals 236,000 in March, near expectations as hiring pace slows
The Labor Department reported Friday that payrolls grew by 236,000 for the month, compared to the Dow Jones estimate for 238,000.
Treasury yields tick up ahead of U.S. jobs report, with many markets closed for holiday
U.S. Treasury yields moved higher as investors await the U.S. jobs report and market sentiment on possibly reactions from the Federal Reserve.
Tesla nominates ex-CTO JB Straubel to board of directors
Tesla has nominated former CTO JB Straubel to join its board of directors, according to a proxy filing out Thursday.
Alzheimer’s patients retain the benefits of Leqembi even when they stop the drug, Eisai says
Alzheimer’s patients who take Leqembi retain the benefits of the treatment even when they stop taking it, new research by Eisai and Biogen shows.
